tiprankstipranks
Trending News
More News >
BioLight Life Sciences Ltd. (IL:BOLT)
:BOLT
Israel Market

Biolight (BOLT) Price & Analysis

Compare
0 Followers

BOLT Stock Chart & Stats


Financials

BOLT FAQ

What was BioLight Life Sciences Ltd.’s price range in the past 12 months?
BioLight Life Sciences Ltd. lowest stock price was 355.00 and its highest was 702.00 in the past 12 months.
    What is BioLight Life Sciences Ltd.’s market cap?
    BioLight Life Sciences Ltd.’s market cap is 22.41M.
      When is BioLight Life Sciences Ltd.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were BioLight Life Sciences Ltd.’s earnings last quarter?
      Currently, no data Available
      Is BioLight Life Sciences Ltd. overvalued?
      According to Wall Street analysts BioLight Life Sciences Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does BioLight Life Sciences Ltd. pay dividends?
        BioLight Life Sciences Ltd. does not currently pay dividends.
        What is BioLight Life Sciences Ltd.’s EPS estimate?
        BioLight Life Sciences Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does BioLight Life Sciences Ltd. have?
        BioLight Life Sciences Ltd. has 4,689,503 shares outstanding.
          What happened to BioLight Life Sciences Ltd.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of BioLight Life Sciences Ltd.?
          Currently, no hedge funds are holding shares in IL:BOLT

          Company Description

          BioLight Life Sciences Ltd.

          BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company's ophthalmic product offering and pipeline of product candidates include DiagnosTear's TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.
          Similar Stocks
          Company
          Price & Change
          Follow
          Xtl Bio
          Bioline Rx
          Can Fite Bio
          Purple Biotech
          Matricelf
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis